ImmunityBio, Inc. IBRX

https://www.defenseworld.net/2026/10/27/immunitybio-inc-ibrx-stake-trimmed-by-davidson-kahn-capital-management-llc.html

OMG WHAT JOKE OF AN ARTICLE. Maybe they should report on me.
I had 550,000 and added 100,000 to total of 650,000

We need POS Jim Cramer to interview Dr PSS on Mad Money and the stock will triple.

The negative is Cramer still called it a spec which is stupid. It has FDA and EMA approvals has sales and showing growth and a solid pipeline of other clinical trials. But the ass hole calls it a spec. I hate that little prick.

If Dr PSS was featured on Mad Money with an interview and interviewed fairly the stock would triple in a month.

The power of the MSM is incredible, infuriating and sickening.

CNBC and FoxB are both show me the ad money if you what fair coverage.

Jim Cramer's show should be named

Show Me The Ad Money not Mad Monet

Cramer said IBRX was a good spec wow

Lightning Round: Don't touch USA Rare Earth, says Jim Cramer https://www.cnbc.com/video/2026/10/26/lightning-round-dont-touch-usa-rare-earth-says-jim-cramer.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard

Now we need Cramer to interview Dr PSS on mad money

IBRX trading makes zero logical sense. So the conclusion is it's all manipulated.

My bet soon the manipulation will be to run it higher.

ImmunityBio needs to buy ad time on CNBC and FoxB and demand they cover the story of Anktiva and ImmunityBio and all the promising clinical tails.

The stock would shoot to $50 plus

So tired of this I try to ignore it

Sick of the slow SP bleed

Let's hope for a good quarterly call